Hubbry Logo
search
logo

Torrent Pharmaceuticals

logo
Community Hub0 Subscribers
Write something...
Be the first to start a discussion here.
Be the first to start a discussion here.
See all
Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics.

Torrent Pharmaceuticals was established in 1959 by U. N. Mehta as Trinity Laboratories. It was renamed Torrent Pharmaceuticals in 1971.

In 1997, Torrent Pharma and Sanofi established a 50:50 joint venture called Sanofi Torrent for selling Torrent Pharma's products. Torrent exited the joint venture by selling its stake to Sanofi in 2002.

In 2005, Torrent Pharmaceuticals acquired Heumann Pharma Generics GmbH, a Pfizer company based in Germany.

In 2013, Torrent Pharma acquired the India formulations business of Elder Pharmaceuticals for 2,004 crore (US$341.99 million).

In 2017, Torrent Pharma acquired the domestic business of Unichem Laboratories for 3,600 crore (US$552.81 million).

In 2022, the company acquired skincare manufacturer Curatio Healthcare for 2,000 crore (US$254.44 million).

See all
User Avatar
No comments yet.